Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study.

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-10-16
DOI
https://doi.org/10.3324/haematol.2025.288776
Citations
1
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study.

Sandra Weißmann, Manja Meggendorfer, Torsten Haferlach, Frank Dicker et al.
1 citations
Haematologica
Chronic Myeloid Leukemia Treatments
1.77
article

Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study.

Sandra Weißmann, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, B. Jung, Caroline Schock
article en
1 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 111(2)
Munich Leukemia Laboratory (Germany) (DE), Offenburg University of Applied Sciences (DE)
Openalex Percentile: Top 12%
Chronic Myeloid Leukemia Treatments
1.77
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.